- Home
- PPBT vs TRNR Comparison
PPBT vs TRNR Comparison
Compare PPBT & TRNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- TRNR
- Stock Information
- Founded
- PPBT 2010
- TRNR 2017
- Country
- PPBT Israel
- TRNR United States
- Employees
- PPBT N/A
- TRNR N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- TRNR Consumer Electronics/Appliances
- Sector
- PPBT Health Care
- TRNR Technology
- Exchange
- PPBT Nasdaq
- TRNR Nasdaq
- Market Cap
- PPBT 6.2M
- TRNR 5.8M
- IPO Year
- PPBT N/A
- TRNR 2023
- Fundamental
- Price
- PPBT $2.31
- TRNR $4.16
- Analyst Decision
- PPBT Strong Buy
- TRNR
- Analyst Count
- PPBT 1
- TRNR 0
- Target Price
- PPBT $33.00
- TRNR N/A
- AVG Volume (30 Days)
- PPBT 269.4K
- TRNR 141.7K
- Earning Date
- PPBT 08-06-2025
- TRNR 08-14-2025
- Dividend Yield
- PPBT N/A
- TRNR N/A
- EPS Growth
- PPBT N/A
- TRNR N/A
- EPS
- PPBT N/A
- TRNR N/A
- Revenue
- PPBT N/A
- TRNR $6,972,000.00
- Revenue This Year
- PPBT N/A
- TRNR $791.08
- Revenue Next Year
- PPBT N/A
- TRNR $123.40
- P/E Ratio
- PPBT N/A
- TRNR N/A
- Revenue Growth
- PPBT N/A
- TRNR 373.32
- 52 Week Low
- PPBT $2.00
- TRNR $3.74
- 52 Week High
- PPBT $13.95
- TRNR $690.00
- Technical
- Relative Strength Index (RSI)
- PPBT 49.88
- TRNR 36.23
- Support Level
- PPBT $2.11
- TRNR $4.05
- Resistance Level
- PPBT $2.31
- TRNR $4.62
- Average True Range (ATR)
- PPBT 0.16
- TRNR 0.44
- MACD
- PPBT 0.01
- TRNR 0.02
- Stochastic Oscillator
- PPBT 72.73
- TRNR 11.83
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About TRNR Interactive Strength Inc.
Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.